Month: September 2018 (Page 3)

On:

Oklahoma approves more than 1,100 medical marijuana businesses, the U.S. Drug Enforcement Administration moves certain CBD medicines off Schedule 1, and New York’s governor signs legislation allowing MMJ as an alternative to opioids. Here’s a closer look at some notable developments in the cannabis industry this week. Oklahoma ‘free-for-all’ TheContinue Reading

On:

Gov. Jerry Brown signs bill making $10 million in initial reparations for the war on marijuana. The post California’s Cannabis Equity Act Just Changed the Game appeared first on Leafly. Read More: California’s Cannabis Equity Act Just Changed the GameContinue Reading

On:

Looking to learn more about terpenes & CBD? Here’s a look at terpene profiles of popular CBD-dominant cannabis strains. The post Which Terpenes Are Found in High-CBD Cannabis Strains? appeared first on Leafly. Read More: Which Terpenes Are Found in High-CBD Cannabis Strains?Continue Reading

On:

Namaste Technologies says it’s on pace to raise $45 million in a bought-deal financing. The firm, which operates an e-commerce platform for cannabis products with more than 30 websites in 20 countries, entered into a letter of engagement under which Eight Capital has agreed to purchase – as co-lead underwriter and jointContinue Reading

On:

Malaysia has opened the door to the possibility of legalizing medical cannabis, but industry sources warn against expecting any immediate breakthrough in the staunchly conservative country. Malaysia eyes possibility of legalizing medical marijuana – but doubt abounds is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news forContinue Reading

On:

More legal cannabis competitions, farmers markets, and concerts are coming thanks to Assembly Bill 2020. The post California Governor OKs Way More Cannabis Events appeared first on Leafly. Read More: California Governor OKs Way More Cannabis EventsContinue Reading

On:

CBD moves from Schedule I to Schedule V, but only for FDA-approved drugs. Everything else is still treated like heroin. The post US Reschedules CBD Drug—but Not CBD Itself appeared first on Leafly. Read More: US Reschedules CBD Drug—but Not CBD ItselfContinue Reading

On:

On Sept. 27, the Drug Enforcement Administration rescheduled Epidiolex, a cannabis-derived medication to treat seizures, so that it now is listed under Schedule V of the 1970 Controlled Substances Act. This rescheduling means that the DEA is acknowledging the drug has a low potential for abuse and has an acceptedContinue Reading